OTCMKTS:SHWZ - Medicine Man Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 60.64 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.49
▼ -0.04 (-1.58%)
1 month | 3 months | 12 months
Get New Medicine Man Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHWZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHWZ

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$4.00
▲ +60.64% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Medicine Man Technologies in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 60.64% upside from the last price of $2.49.

Buy

The current consensus among 1 contributing investment analysts is to buy stock in Medicine Man Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/24/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/27/2020Noble FinancialReiterated RatingBuy$4.00
i
(Data available from 6/16/2016 forward)
Medicine Man Technologies logo
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company provides cannabis products for various edible companies; and vape cartridges and syringes. As of March 17, 2021, it owned and operated 17 dispensaries in Colorado under the brand name Star Buds. In addition, the company provides consulting services for cannabis businesses; and Three A Light, cannabis grower's guide book. Further, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is based in Denver, Colorado.
Read More

Today's Range

Now: $2.49
$2.45
$2.55

50 Day Range

MA: $2.45
$2.08
$2.82

52 Week Range

Now: $2.49
$1.05
$3.25

Volume

100,017 shs

Average Volume

153,267 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Medicine Man Technologies?

The following equities research analysts have issued research reports on Medicine Man Technologies in the last twelve months: Noble Financial.
View the latest analyst ratings for SHWZ.

What is the current price target for Medicine Man Technologies?

1 Wall Street analysts have set twelve-month price targets for Medicine Man Technologies in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 60.6%. Noble Financial has the highest price target set, predicting SHWZ will reach $4.00 in the next twelve months. Noble Financial has the lowest price target set, forecasting a price of $4.00 for Medicine Man Technologies in the next year.
View the latest price targets for SHWZ.

What is the current consensus analyst rating for Medicine Man Technologies?

Medicine Man Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SHWZ will outperform the market and that investors should add to their positions of Medicine Man Technologies.
View the latest ratings for SHWZ.

What other companies compete with Medicine Man Technologies?

Other companies that are similar to Medicine Man Technologies include AllyMe Group, ALS, American Cannabis, Fintel, Igeamed, Intertek Group, SEC Newgate, SGD and Teleperformance.

How do I contact Medicine Man Technologies' investor relations team?

The company's listed phone number is (303) 371-0387. The official website for Medicine Man Technologies is www.schwazze.com.